High dose neostigmine treatment of malignant sinus tachycardia

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 5 I, 1997, Pages 1369-1372

  Schultheis, Lex W ^a,b   Balser, Jeffrey R ^a   Calkins, Hugh ^a   Robertson, Shawn ^a   Weiss, James L ^a   Sussman, Marc ^a   Stuart, R Scott ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

acetylcholinesterase inhibitors; cardiogenic shock; neostigmine; sinus tachycardia

Indexed keywords

ESMOLOL; NEOSTIGMINE;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CARDIOGENIC SHOCK; CASE REPORT; CATHETER ABLATION; FEMALE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; SINUS TACHYCARDIA; WOLFF PARKINSON WHITE SYNDROME;

ADULT; CATECHOLAMINES; CHOLINESTERASE INHIBITORS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; NEOSTIGMINE; TACHYCARDIA, SINUS;

EID: 0030972228     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb06795.x     Document Type: Article

References (7)

1. Macintosh RR. Death following injection of neostigmine. Br Med J 1949; 1:852.
2. Moss AJ, Aledort LM. Use of edrophonium in the evaluation of supraventricular tachycardias. Am J Cardiol 1966; 17:58.
3. Eldor J, Frankel DZN. Use of low-dose neostigmine intravenously in the treatment of supraventricular tachycardia: An immediate bradycardic effect. Resuscitation 1989; 18:103-110.
4. Hope EJ, Haigney MC, Calkins H, et al. Left main coronary thrombosis after radiofrequency ablation: Successful treatment with percutaneous transluminal angioplasty. Am Heart J 1995; 129:1217.
5. Milne MR, Crosse MM. Neostigmine or β-blockers? A pharmacologic conundrum. J Cardiothorac Vasc Anesth 1993; 7:593-594.
6. Watanabe AM, Bailey JC, Lathrop D, et al. Acetylcholine antagonism of the cellular electrophysiologic effects of isoproterenol. In PJ Schwartz, AM Brown, Malliani, et al. (eds.): Neural Mechanisms in Cardiac Arrhythmias. New York, NY, Raven Press, 1978, pp. 349-358.
7. Schultheis AH, Bassett DJP, Fryer AD. Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function. J Appl Physiol 1994; 76:1088-1097.